News coverage about Safeguard Scientifics (NYSE:SFE) has been trending somewhat positive recently, according to AlphaOne Sentiment. The research firm, a subsidiary of Accern, identifies positive and negative press coverage by reviewing more than 20 million news and blog sources in real-time. AlphaOne ranks coverage of publicly-traded companies on a scale of negative one to one, with scores nearest to one being the most favorable. Safeguard Scientifics earned a coverage optimism score of 0.17 on AlphaOne’s scale. AlphaOne also assigned news stories about the asset manager an impact score of 31 out of 100, meaning that recent press coverage is unlikely to have an impact on the stock’s share price in the next several days.
Here are some of the media headlines that may have impacted AlphaOne Sentiment Analysis’s analysis:
- Safeguard Scientifics, Inc (SFE) Downgraded by ValuEngine to Strong Sell (americanbankingnews.com)
- BRIEF-Safeguard Scientifics enters into new $75 mln secured credit facility (reuters.com)
- Sample Preparation Market is Expected to Cross US$ 8.0 Billion Globally by 2024 (openpr.com)
- New AI Cloud Platform by Prognos Transforms Member Lab Data to Address Business Challenges for Payers (investor.wedbush.com)
- Safeguard Scientifics Enters into $75M Secured Credit Facility to Pursue Long-term Growth Opportunities (seekingalpha.com)
Shares of Safeguard Scientifics (NYSE:SFE) traded down 3.10% during mid-day trading on Wednesday, hitting $10.95. 106,927 shares of the stock were exchanged. Safeguard Scientifics has a 12 month low of $10.60 and a 12 month high of $14.38. The firm’s market cap is $222.93 million. The stock’s 50 day moving average is $12.25 and its 200 day moving average is $12.33.
Safeguard Scientifics (NYSE:SFE) last announced its quarterly earnings results on Friday, April 28th. The asset manager reported ($1.08) EPS for the quarter, missing the consensus estimate of ($0.53) by $0.55. During the same quarter in the previous year, the firm posted ($0.76) earnings per share. Analysts expect that Safeguard Scientifics will post ($2.23) EPS for the current fiscal year.
A number of analysts have recently commented on SFE shares. Zacks Investment Research cut shares of Safeguard Scientifics from a “buy” rating to a “hold” rating in a report on Thursday, May 4th. ValuEngine cut shares of Safeguard Scientifics from a “sell” rating to a “strong sell” rating in a report on Tuesday.
WARNING: This story was originally posted by sleekmoney and is the property of of sleekmoney. If you are viewing this story on another domain, it was illegally stolen and republished in violation of United States and international trademark & copyright law. The correct version of this story can be viewed at https://sleekmoney.com/safeguard-scientifics-sfe-receiving-somewhat-favorable-press-coverage-report-finds/1830799.html.
Safeguard Scientifics Company Profile
Safeguard Scientifics, Inc is engaged in providing capital to technology companies within the fields of healthcare, financial services and digital media. The Company holds interest in companies, which it refers to as partner companies. As of December 31, 2016, the Company held interests in 29 non-consolidated partner companies.
This story was originally published by sleekmoney (https://sleekmoney.com) and is the sole property of sleekmoney. If you are reading this article on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. You can view the original version of this story at https://sleekmoney.com/safeguard-scientifics-sfe-receiving-somewhat-favorable-press-coverage-report-finds/1830799.html
Receive News & Ratings for Safeguard Scientifics Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Safeguard Scientifics Inc and related companies with MarketBeat.com's FREE daily email newsletter.